CATHERINE LUZ: Open Payments
NPI 1578080651 · RIVERSIDE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 58 payments from 16 companies in 2025. Trend: 2023 $1,009 · 2024 $1,257 · 2025 $1,423
Food & beverage: $1,158Education: $266
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $370 |
| Regeneron Healthcare Solutions, Inc. | 7 | $228 |
| Janssen Biotech, Inc. | 6 | $154 |
| E.R. Squibb & Sons, L.L.C. | 4 | $135 |
| Amgen Inc. | 2 | $129 |
| GENZYME CORPORATION | 3 | $110 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Incyte Corporation | 1 | $30 |
| Verrica Pharmaceuticals Inc. | 1 | $25 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, RINVOQ, Sotyktu, OTEZLA, COSENTYX, OPZELURA.
Industry payments across RI — which companies pay providers there.
